The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on October 7, 2026, at 6:30 PM CEST (8:30 PM AMT).

This live educational webinar will examine how new concepts and therapeutic strategies are reshaping the management of relapsed ovarian cancer, with particular attention to evolving treatment classifications and the growing role of antibody–drug conjugates (ADCs).

The expert discussion will address how emerging therapies may be integrated and sequenced within current treatment pathways, providing practical insights for clinicians managing patients with recurrent disease. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.